Circulating concentrations of proinflammatory cytolcines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
Abstract
Proinflammatory cytokines are capable of modulating cardiovascular function by a variety of mechanisms. These cytokines are elevated in patients with severe heart failure, but changes in mild or moderate heart failure have not been reported. Therefore, simultaneous arterial and coronary sinus concentrations of interleukin-1alpha, soluble interleukin-2 receptor, interleukin-6, and tumor necrosis factor-alpha were measured in 78 patients with New York Heart Association functional class II to IV heart failure and compared with 17 healthy volunteers. Concentrations of interleukin-1alpha, soluble interleukin-2 receptor, and interleukin-6 were determined by a "sandwich" enzyme-linked immunosorbent assay and tumor necrosis factor-alpha by tissue culture technique. There were no statistical differences in interleukin-1alpha, soluble interleukin-2 receptor, or tumor necrosis factor-alpha concentrations in mild to moderate heart failure versus control subjects. Interleukin-6 was significantly elevated, 75 +/- 16 versus 0.4 +/- 0.4pg/ml (p = 0.002). Cytokine concentrations did not differ by heart failure etiology. Paired arterial and coronary sinus concentrations were not significantly different. Soluble interleukin-2 receptor concentrations were significantly correlated with New York Heart Association functional class (r = 0.59, p = 0.04) and negatively associated with exercise tolerance time (r = -0.59, p = 0.007). Thus, interleukin-6 is significantly elevated in mild or moderate heart failure.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Patients with heart failure have alterations in intestinal integrity, and elevated levels of pro-inflammatory cytokines in the blood correlate with symptom severity and poorer outcomes.
“Multiple studies show patients with heart failure have alterations in intestinal integrity, and that elevated levels of pro-inflammatory cytokines in the blood correlate with symptom severity and poorer outcomes20, 21.”
From Gut microbiota and cardiovascular disease. (2020) · cites this paper as [20]
Intestinal absorption of endotoxin is a significant stimulus for systemic increases in inflammatory cytokines during heart failure.
“There is evidence that the intestinal absorption of endotoxin is a significant stimulus for systemic increases in inflammatory cytokines during heart failure41,42.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [41]
Cites
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
Levine, B., Kalman, J., Mayer, L., Fillit, H. M., & Packer, M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007263230405 · Cited by 2,582 · see citing works
Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine
Peuler, J. D., & Johnson, G. A. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90070-4 · Cited by 1,899 · see citing works
Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric Oxide
Finkel, M. S., Oddis, C. V., Jacob, T. D., Watkins, S. C., Hattler, B. G. J., & Simmons, R. L. (1992) · Science · doi:10.1126/science.1631560 · Cited by 1,626 · see citing works
Yokoyama, T., Vaca, L. A., Rossen, R. D., Durante, W., Hazarika, P., & Mann, D. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116834 · Cited by 714 · see citing works
Natanson, C., Eichenholz, P. W., Danner, R. L., Eichacker, P. Q., Hoffman, W. D., Kuo, G. C., Banks, S. M., MacVittie, T. J., & Parrillo, J. E. (1989) · The Journal of Experimental Medicine · doi:10.1084/jem.169.3.823 · Cited by 566 · see citing works
Fowler, M. B., Laser, J., Hopkins, G. L., et al. (1986) · Circulation · doi:10.1161/01.cir.74.6.1290 · Cited by 565 · see citing works
Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness.
Gulick, T., Chung, M. K., Pieper, S. J., Lange, L. G., & Schreiner, G. F. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.17.6753 · Cited by 495 · see citing works
Purification and physico-chemical characterization of rabbit tumor necrosis factor.
Ruff, M. R., & Gifford, G. E. (1980) · The Journal of Immunology · doi:10.4049/jimmunol.125.4.1671 · Cited by 387 · see citing works
Basic Mechanisms in Congestive Heart Failure
Mann, D. L., & Young, J. B. (1994) · CHEST Journal · doi:10.1378/chest.105.3.897 · Cited by 365 · see citing works
McMurray, J. J. V., Abdullah, I., Dargie, H. J., & Shapiro, D. (1991) · Heart · doi:10.1136/hrt.66.5.356 · Cited by 344 · see citing works
Hypoxic Stress Induces Cardiac Myocyte–Derived Interleukin-6
Yamauchi‐Takihara, K., Ihara, Y., Ogata, A., Yoshizaki, K., Azuma, J., & Kishimoto, T. (1995) · Circulation · doi:10.1161/01.cir.91.5.1520 · Cited by 303 · see citing works
Pagani, F. D., Baker, L. S., Hsi, C. C., Knox, M. A., Fink, M. P., & Visner, M. S. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115873 · Cited by 277 · see citing works
Elevated plasma interleukin-6 levels in patients with acute myocardial infarction
Miyao, Y., Yasue, H., Ogawa, H., Misumi, I., 増田, 武., Sakamoto, T., & Morita, E. (1993) · American Heart Journal · doi:10.1016/0002-8703(93)90526-f · Cited by 205 · see citing works
Hegewisch, S. (1990) · The Lancet · doi:10.1016/0140-6736(90)90115-l · Cited by 187 · see citing works
Volpe, M., Tritto, C., Testa, U., et al. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90905-9 · Cited by 148 · see citing works
Blum, A., Sclarovsky, S., Rehavia, E., & Shohat, B. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90040-x · Cited by 122 · see citing works
TNF-alpha release in endotoxemia contributes to neutrophil-dependent pulmonary edema
Horgan, M. J., Palace, G. P., Everitt, J., et al. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.264.4.h1161 · Cited by 51 · see citing works
Villareal, D. T., & Morley, J. E. (1994) · Drugs & Aging · doi:10.2165/00002512-199404060-00005 · Cited by 41 · see citing works
Lymphokines and the immune response
Jacob, C. O. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90059-3 · Cited by 32 · see citing works
Arterial oxygen saturation in chronic congestive heart failure
Munger, M. A., Stanek, E. J., Nara, A. R., Strohl, K. P., Decker, M. J., & Nair, R. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90211-9 · Cited by 29 · see citing works
Self-citationLymphokines and the immune response
Cohen, S. A. (1990) · CRC Press eBooks · Cited by 25 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Gut microbiota and cardiovascular disease.
Witkowski, M., Weeks, T. L., & Hazen, S. L. (2020) · Circulation Research · doi:10.1161/circresaha.120.316242 · Cited by 1,051 · see citing works
Endotoxin and immune activation in chronic heart failure: a prospective cohort study
Niebauer, J., Volk, H.-D., Kemp, M., Dominguez, M., Schumann, R. R., Rauchhaus, M., Poole-Wilson, P. A., Coats, A. J., & Anker, S. D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09286-1 · Cited by 877 · see citing works
Dietary metabolism, the gut microbiome, and heart failure
Tang, W. H. W., Li, D. Y., & Hazen, S. L. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0108-7 · Cited by 789 · see citing works
Elevated soluble CD14 receptors and altered cytokines in chronic heart failure
Anker, S. D., Egerer, K. R., Volk, H.-D., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00159-8 · Cited by 392 · see citing works
Goebel, M. U., Mills, P. J., Irwin, M. R., & Ziegler, M. G. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200007000-00019 · Cited by 189 · see citing works
Peschel, T., Schönauer, M., Thiele, H., Anker, S., Schuler, G., & Niebauer, J. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(03)00104-1 · Cited by 187 · see citing works
Marfella, R., Esposito, K., Siniscalchi, M., Cacciapuoti, F., Giugliano, F., Labriola, D., Ciotola, M., Di Palo, C., Misso, L., & Giugliano, D. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.47 · Cited by 170 · see citing works
How are Cytokines Activated in Heart Failure?
Paulus, W. J. (1999) · European Journal of Heart Failure · doi:10.1016/s1388-9842(99)00049-5 · Cited by 72 · see citing works
Kinugawa, T., Kato, M., Ogino, K., Osaki, S., Tomikura, Y., Igawa, O., Hisatome, I., & Shigemasa, C. (2003) · International Journal of Cardiology · doi:10.1016/s0167-5273(02)00200-0 · Cited by 48 · see citing works
- Authors
- Munger, M. A., Johnson, B., Amber, I. J., Callahan, K. S., & Gilbert, E. M.
- Affiliations
- University of Utah (US)
- Corresponding author
- Gilbert, Edward M.
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 1996-04
- Volume
- 77
- Issue
- 9
- Pages
- 723-727
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2162460000
- Cited by
- 237
- References
- 21
- Citations by year
- 2026: 2 · 2024: 4 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 4 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 7 · 2015: 5 · 2014: 4 · 2013: 4 · 2012: 7
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- heart failure, inflammatory cytokines, interleukin-6, interleukin-1 alpha, soluble interleukin-2 receptor, TNF-α, dilated cardiomyopathy, ischemic cardiomyopathy, NYHA functional class, exercise tolerance
- MeSH terms
- Adrenergic alpha-Agonists, Arteries, Cardiac Output, Low, Cardiomyopathy, Dilated, Coronary Vessels, Enzyme-Linked Immunosorbent Assay, Female, Humans, Interleukin-1, Male, Middle Aged, Norepinephrine, Stroke Volume, Tumor Necrosis Factor-alpha, Receptors, Interleukin-2, Interleukin-6, Cytokines, Ventricular Function, Left, Exercise Tolerance, Myocardial Ischemia, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review